As CSO of Aifred Health, David provides strategic scientific direction and acts as a bridge between the machine learning and clinical team. He is also a Psychiatry Resident and Researcher at McGill University. He obtained his MD.,CM at McGill and an MSc (Neuroscience-Distinction) from University College London.
Robert Fratila is a Co-Founder and VP of AI at Aifred Health. Trained in computer science and biology, his passion for combining medicine and AI throughout his work and research has grown extraordinarily. As a software developer at the Montreal Neurological Institute, he worked on integrating state-of-the-art deep learning techniques in the healthcare industry, specifically brain imaging. This has given him valuable experience in finding efficient solutions to complex problems. As a cofounder of Aifred Health, he managed machine learning research and product engineering teams, producing world-leading software and extremely promising results for mental health care.
He has also given many invited talks and workshops about his work and research at a variety of events, including the Canadian University Software Engineering Conference (CUSEC) and the Sixth Biennial Conference on Resting State and Brain Connectivity. He is committed to spreading knowledge and demystifying the wonderful field of machine learning.
Sonia holds a BSc in Honours Neuroscience from McGill University, where she founded the student neurotechnology group that eventually gave rise to Aifred Health. As a lifelong entrepreneur, Sonia appreciates the value of strategic business leadership to effect change in clinical practice. She continuously strives to help enhance the interface between leading research and neurological health care.
Kelly Perlman, a graduate neuroscience student in McGill’s integrated program in neuroscience, is a co-founder of Aifred Health. She is also the director of research and has the primary goal of ensuring that every step in the development of the product is firmly grounded in science. Her responsibilities include conducting systematic reviews of relevant scientific literature along with the research team, assessing the feasibility of biomarker implementation, and planning for future clinical trials. She has conducted research in laboratories studying neuroimaging and neuroimmunology. Kelly is immensely passionate about all things science and she is dedicated to ensuring that Aifred Health stays at the forefront of biomedical innovation.
Caitrin holds a BA&Sc in Cognitive Science and an MSc in Computer Science, both from McGill University. She has extensive expertise in applying computational techniques to new domains with complex human data, including work in software development for mental health, and as a researcher in computational social science. She is thrilled to put this knowledge to work and lead Aifred’s development efforts to produce a revolutionary evidence-based AI tool.
Charlie Gower has 20 years of years of product design and research experience in digital and physical domains both at startups he founded and at multinationals. With tenure in leadership roles at agencies, startups, and working in house across Europe and the US, Charlie brings experience in healthcare from the consumer side as well as the hospital side. Having invented services for 100M Chinese teenagers, to executive tools used by 10, he's excited to be on the Aifred journey.
Janaka is a seasoned engineer and product owner leading the Aifred product development team.
A seasoned business leader with more than 15 years senior management experience, Ms. Massingham has held senior roles at management consultancy Kaiser Associates, Cadbury and Novartis. Ms. Massingham also brings Canadian healthcare startup experience to the Aifred team, having co-founded Canadian pharmaceutical startup TeOra Health, acquired by Aequus Pharmaceuticals in 2015. Most recently, she served as VP Marketing for Aequus, prior to joining Aifred Health. Based in Montréal since 2013, Ms. Massingham holds a Bachelor of Science from the University of Leeds and a Masters in International Management from King’s College, London.
Donald is an experienced life sciences executive, entrepreneur and director with significant experience raising capital for private and public technology companies. Most recently, he was President and CEO of Montreal-based NEOMED Institute, a position he held until the successful closing of a merger with Vancouver-based CDRD. He has held multiple executive positions as CEO, COO and CFO of private and public life science and technology companies and began his business career as a commercial, corporate and investment banker working across a variety of industry verticals. Mr. Olds has significant corporate governance experience as a board member and chair of both for profit and not for profit organizations. He is currently lead director at Goodfood Markets (TSX:FOOD), director of Acasti Pharma (NASDAQ:ACST), past Chair of Oxfam Quebec and director of private Presagia Corp. He holds an MBA and M.Sc. from McGill University.